Zurcher Kantonalbank (Zurich Cantonalbank) - CATALYST PHARMACEUTICALS INC ownership

CATALYST PHARMACEUTICALS INC's ticker is CPRX and the CUSIP is 14888U101. A total of 138 filers reported holding CATALYST PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 1.04 and the average weighting 0.1%.

Quarter-by-quarter ownership
Zurcher Kantonalbank (Zurich Cantonalbank) ownership history of CATALYST PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$288,649
+9.3%
24,692
+25.7%
0.00%0.0%
Q2 2023$264,069
-18.9%
19,6480.0%0.00%
-50.0%
Q1 2023$325,764
+15.1%
19,648
+29.1%
0.00%0.0%
Q4 2022$283,148
+137.9%
15,223
+64.8%
0.00%
+100.0%
Q3 2022$119,000
+83.1%
9,2400.0%0.00%
Q2 2022$65,000
-52.6%
9,240
-44.1%
0.00%
-100.0%
Q1 2022$137,000
+144.6%
16,535
+99.8%
0.00%
Q4 2021$56,000
+51.4%
8,277
+19.9%
0.00%
Q3 2021$37,000
-7.5%
6,9040.0%0.00%
Q2 2021$40,000
+25.0%
6,9040.0%0.00%
Q1 2021$32,000
+39.1%
6,9040.0%0.00%
Q4 2020$23,000
+9.5%
6,9040.0%0.00%
Q3 2020$21,000
-34.4%
6,9040.0%0.00%
Q2 2020$32,000
+18.5%
6,9040.0%0.00%
Q1 2020$27,000
+3.8%
6,9040.0%0.00%
Q4 2019$26,000
-29.7%
6,9040.0%0.00%
Q3 2019$37,000
+54.2%
6,904
+9.4%
0.00%
Q2 2019$24,0006,3090.00%
Other shareholders
CATALYST PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
TANAKA CAPITAL MANAGEMENT INC 208,189$1,726,0003.48%
FRIESS ASSOCIATES LLC 571,940$4,741,0002.53%
GABLES CAPITAL MANAGEMENT INC. 438,764$3,637,0002.28%
Prairiewood Capital, LLC 258,073$2,139,0001.50%
Quantedge Capital Pte Ltd 597,300$4,952,0001.46%
ARMISTICE CAPITAL, LLC 8,372,000$69,404,0001.34%
SummerHaven Investment Management, LLC 158,473$1,314,0000.74%
Capital Impact Advisors, LLC 99,322$823,0000.60%
EAM Investors, LLC 365,415$3,029,0000.56%
GLOBEFLEX CAPITAL L P 304,515$2,524,0000.51%
View complete list of CATALYST PHARMACEUTICALS INC shareholders